Spectral AI, Inc. (NASDAQ: MDAI) Stock Competitors & Peer Comparison
See MDAI's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MDAI and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDAI | $1.73 | +10.19% | 55.1M | -3.84 | -$0.45 | N/A |
| ALC | $73.52 | -0.08% | 35.8B | 23.11 | $3.18 | +0.49% |
| STE | $236.07 | -0.22% | 23B | 22.65 | $10.42 | +1.07% |
| BRKRP | $433.26 | -1.08% | 8.6B | 234.03 | $1.84 | +0.34% |
| DRTSW | $3.89 | +8.96% | 1.5B | -6.02 | -$0.65 | N/A |
| MASS | $10.11 | +0.90% | 414.8M | -16.85 | -$0.60 | N/A |
| SI | $19.23 | -0.57% | 398.8M | -10.04 | -$1.91 | N/A |
| MOBI | $11.68 | +1.39% | 388.3M | -0.62 | -$18.78 | N/A |
| EDAP | $4.76 | -0.52% | 178.2M | -5.80 | -$0.82 | N/A |
| NYXH | $1.58 | +0.00% | 158.1M | -0.63 | -$2.52 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
MDAI vs ALC Comparison August 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 55.1M. In comparison, ALC has a market cap of 35.8B. Regarding current trading prices, MDAI is priced at $1.73 on the NASDAQ, while ALC trades at $73.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.84, whereas ALC's P/E ratio is 23.11. In terms of profitability, MDAI's ROE is +1.21%, compared to ALC's ROE of +0.03%. Regarding short-term risk, MDAI is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check ALC's competition here
STERIS plc (NYSE: STE)
MDAI vs STE Comparison August 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 55.1M. In comparison, STE has a market cap of 23B. Regarding current trading prices, MDAI is priced at $1.73 on the NASDAQ, while STE trades at $236.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.84, whereas STE's P/E ratio is 22.65. In terms of profitability, MDAI's ROE is +1.21%, compared to STE's ROE of +0.11%. Regarding short-term risk, MDAI is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check STE's competition here
Bruker Corporation (NASDAQ: BRKRP)
MDAI vs BRKRP Comparison August 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 55.1M. In comparison, BRKRP has a market cap of 8.6B. Regarding current trading prices, MDAI is priced at $1.73 on the NASDAQ, while BRKRP trades at $433.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.84, whereas BRKRP's P/E ratio is 234.03. In terms of profitability, MDAI's ROE is +1.21%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, MDAI is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check BRKRP's competition here
Alpha Tau Medical Ltd. (NASDAQ: DRTSW)
MDAI vs DRTSW Comparison August 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 55.1M. In comparison, DRTSW has a market cap of 1.5B. Regarding current trading prices, MDAI is priced at $1.73 on the NASDAQ, while DRTSW trades at $3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.84, whereas DRTSW's P/E ratio is -6.02. In terms of profitability, MDAI's ROE is +1.21%, compared to DRTSW's ROE of -1.38%. Regarding short-term risk, MDAI is less volatile compared to DRTSW. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check DRTSW's competition here
908 Devices Inc. (NASDAQ: MASS)
MDAI vs MASS Comparison August 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 55.1M. In comparison, MASS has a market cap of 414.8M. Regarding current trading prices, MDAI is priced at $1.73 on the NASDAQ, while MASS trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.84, whereas MASS's P/E ratio is -16.85. In terms of profitability, MDAI's ROE is +1.21%, compared to MASS's ROE of -0.25%. Regarding short-term risk, MDAI is more volatile compared to MASS. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check MASS's competition here
Shoulder Innovations, Inc. (NYSE: SI)
MDAI vs SI Comparison August 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 55.1M. In comparison, SI has a market cap of 398.8M. Regarding current trading prices, MDAI is priced at $1.73 on the NASDAQ, while SI trades at $19.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.84, whereas SI's P/E ratio is -10.04. In terms of profitability, MDAI's ROE is +1.21%, compared to SI's ROE of -0.24%. Regarding short-term risk, MDAI is more volatile compared to SI. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
MDAI vs MOBI Comparison August 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 55.1M. In comparison, MOBI has a market cap of 388.3M. Regarding current trading prices, MDAI is priced at $1.73 on the NASDAQ, while MOBI trades at $11.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.84, whereas MOBI's P/E ratio is -0.62. In terms of profitability, MDAI's ROE is +1.21%, compared to MOBI's ROE of -15.96%. Regarding short-term risk, MDAI is more volatile compared to MOBI. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check MOBI's competition here
Edap Tms S.a. (NASDAQ: EDAP)
MDAI vs EDAP Comparison August 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 55.1M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, MDAI is priced at $1.73 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.84, whereas EDAP's P/E ratio is -5.80. In terms of profitability, MDAI's ROE is +1.21%, compared to EDAP's ROE of -1.49%. Regarding short-term risk, MDAI is more volatile compared to EDAP. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
MDAI vs NYXH Comparison August 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 55.1M. In comparison, NYXH has a market cap of 158.1M. Regarding current trading prices, MDAI is priced at $1.73 on the NASDAQ, while NYXH trades at $1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.84, whereas NYXH's P/E ratio is -0.63. In terms of profitability, MDAI's ROE is +1.21%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, MDAI is more volatile compared to NYXH. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check NYXH's competition here
Apyx Medical Corporation (NASDAQ: APYX)
MDAI vs APYX Comparison August 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 55.1M. In comparison, APYX has a market cap of 128M. Regarding current trading prices, MDAI is priced at $1.73 on the NASDAQ, while APYX trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.84, whereas APYX's P/E ratio is -13.82. In terms of profitability, MDAI's ROE is +1.21%, compared to APYX's ROE of -0.79%. Regarding short-term risk, MDAI is more volatile compared to APYX. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check APYX's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
MDAI vs WOK Comparison August 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 55.1M. In comparison, WOK has a market cap of 5.1M. Regarding current trading prices, MDAI is priced at $1.73 on the NASDAQ, while WOK trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.84, whereas WOK's P/E ratio is N/A. In terms of profitability, MDAI's ROE is +1.21%, compared to WOK's ROE of -0.07%. Regarding short-term risk, MDAI is more volatile compared to WOK. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check WOK's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
MDAI vs FEED Comparison August 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 55.1M. In comparison, FEED has a market cap of 3.7M. Regarding current trading prices, MDAI is priced at $1.73 on the NASDAQ, while FEED trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.84, whereas FEED's P/E ratio is -0.01. In terms of profitability, MDAI's ROE is +1.21%, compared to FEED's ROE of -0.44%. Regarding short-term risk, MDAI is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check FEED's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
MDAI vs QTEXW Comparison August 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 55.1M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, MDAI is priced at $1.73 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.84, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, MDAI's ROE is +1.21%, compared to QTEXW's ROE of N/A. Regarding short-term risk, MDAI is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
MDAI vs ITOC Comparison August 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 55.1M. In comparison, ITOC has a market cap of 2.7M. Regarding current trading prices, MDAI is priced at $1.73 on the NASDAQ, while ITOC trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.84, whereas ITOC's P/E ratio is -0.94. In terms of profitability, MDAI's ROE is +1.21%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, MDAI is more volatile compared to ITOC. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check ITOC's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAFW)
MDAI vs BIAFW Comparison August 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 55.1M. In comparison, BIAFW has a market cap of 2.5M. Regarding current trading prices, MDAI is priced at $1.73 on the NASDAQ, while BIAFW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.84, whereas BIAFW's P/E ratio is 0.27. In terms of profitability, MDAI's ROE is +1.21%, compared to BIAFW's ROE of -2.57%. Regarding short-term risk, MDAI is less volatile compared to BIAFW. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check BIAFW's competition here